{
    "clinical_study": {
        "@rank": "125897", 
        "acronym": "TODI", 
        "arm_group": [
            {
                "arm_group_label": "Combined", 
                "arm_group_type": "Experimental", 
                "description": "Group cognitive-behavior therapy for depression combined with behavior modification for weight loss"
            }, 
            {
                "arm_group_label": "GCBT-ND", 
                "arm_group_type": "Active Comparator", 
                "description": "Group cognitive-behavior therapy for depression combined with an alternative approach to weight loss"
            }, 
            {
                "arm_group_label": "DSE", 
                "arm_group_type": "Active Comparator", 
                "description": "Behavior modification for weight loss combined with depression support and education."
            }
        ], 
        "brief_summary": {
            "textblock": "To determine whether individuals who suffer from depression and obesity are able to lose\n      weight and show improvements in mood and cardiovascular disease risk factors following 20\n      weeks of a combined treatment of cognitive-behavior therapy for depression and behavior\n      modification for weight loss. Participants will be assigned to one of three treatments: 1)\n      cognitive-behavior therapy for the treatment of depression combined with an alternative\n      approach to weight loss, 2)  a weight loss intervention combined with a depression support\n      and education , or 3) cognitive-behavioral therapy for depression combined with a weight\n      loss intervention."
        }, 
        "brief_title": "Treatment for Depressed, Obese Individuals at Risk for Cardiovascular Disease (CVD)", 
        "condition": [
            "Obesity", 
            "Major Depressive Disorder", 
            "Dysthymic Disorder", 
            "Cardiovascular Disease"
        ], 
        "condition_browse": {
            "mesh_term": [
                "Cardiovascular Diseases", 
                "Depressive Disorder", 
                "Depression", 
                "Dysthymic Disorder", 
                "Obesity", 
                "Depressive Disorder, Major"
            ]
        }, 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion Criteria\n\n          -  Female and male participants, with a BMI of 27 kg/m2 to 45 kg/m2\n\n          -  Age 18 - 70 years old\n\n          -  Presence of current major depressive disorder or dysthymic disorder\n\n          -  At least 2 CVD risk factors, as characterized by the metabolic syndrome, including:\n\n               -  Elevated waist circumference (males 40 inches or 102 cm; females 35 inches of 88\n                  cm)\n\n               -  Fasting blood glucose 100 mg/dL\n\n               -  Blood pressure 130/85 mm Hg\n\n               -  Triglycerides 150 mg/dL\n\n               -  Reduced HDL cholesterol (males 40 mg/dL; females 50 mg/dL)\n\n               -  OR medications for these conditions\n\n          -  Able to comply will all study procedures and schedule\n\n          -  Able to speak and read English\n\n        Exclusion Criteria\n\n          -  Cardiovascular event (e.g., myocardial infarction, stroke) within the past 12 months\n\n          -  Use of tricyclic anti-depressants, monoamine oxidase inhibitors or paroxetine, mood\n             stabilizers, or antipsychotic medications. (Note: participants who take SSRI/SNRI may\n             be acceptable, provided they have been on a stable dose of these medications 3\n             months.)\n\n          -  Use of weight-loss medications or any medications known to significantly affect\n             weight (e.g., oral steroids) in past 3 months\n\n          -  Weight loss of 5% or more in past 6 months\n\n          -  Enrollment in weight reduction program in prior 3 months\n\n          -  Treatment in individual psychotherapy for any psychiatric disorder in prior 3 months\n             (Note: participants in couples or family counseling will be allowed.)\n\n          -  Severe depression or severe impairment of functioning as judged by the assessor or PI\n\n          -  Presence of active suicidal ideation\n\n          -  Diabetes\n\n          -  Alcohol/drug abuse/dependence\n\n          -  Renal/hepatic disease\n\n          -  Change in thyroid medications in last 3 months\n\n          -  Pregnant/lactating, within 6-months post-partum\n\n          -  Current diagnoses, or history within the last 5 years, of anorexia or bulimia\n\n          -  Psychotic symptoms or hospitalization for a psychiatric disorder in previous 12\n             months\n\n          -  Mood disorder NOS, substance-induced mood disorders, mood disorders due to a general\n             medical condition\n\n          -  History of bipolar disorder\n\n          -  History of head trauma\n\n          -  Any changes in smoking behavior in prior 3 months (or plans to change in the next 3\n             months)\n\n          -  Plans for bariatric surgery\n\n          -  Any other uncontrolled major medical problems\n\n          -  Women who are pregnant"
            }, 
            "gender": "Both", 
            "healthy_volunteers": "No", 
            "maximum_age": "70 Years", 
            "minimum_age": "18 Years"
        }, 
        "enrollment": {
            "#text": "90", 
            "@type": "Anticipated"
        }, 
        "firstreceived_date": "September 20, 2012", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT01692574", 
            "org_study_id": "813829"
        }, 
        "intervention": [
            {
                "arm_group_label": [
                    "Combined", 
                    "DSE"
                ], 
                "intervention_name": "Behavior Modification for Weight Loss", 
                "intervention_type": "Behavioral"
            }, 
            {
                "arm_group_label": "GCBT-ND", 
                "intervention_name": "Alternative Approach to Weight Loss", 
                "intervention_type": "Behavioral"
            }, 
            {
                "arm_group_label": [
                    "Combined", 
                    "GCBT-ND"
                ], 
                "intervention_name": "Cognitive-Behavior Therapy for Depression", 
                "intervention_type": "Behavioral"
            }, 
            {
                "arm_group_label": "DSE", 
                "intervention_name": "Depression Support and Education", 
                "intervention_type": "Behavioral"
            }
        ], 
        "is_fda_regulated": "No", 
        "keyword": "depression and obesity treatment", 
        "lastchanged_date": "March 20, 2014", 
        "location": {
            "contact": {
                "email": "cbechtel@mail.med.upenn.edu", 
                "last_name": "Colleen Bechtel, MS", 
                "phone": "215-573-5502"
            }, 
            "facility": {
                "address": {
                    "city": "Philadelphia", 
                    "country": "United States", 
                    "state": "Pennsylvania", 
                    "zip": "19104"
                }, 
                "name": "University of Pennsylvania: Center for Weight and Eating Disorders"
            }, 
            "investigator": {
                "last_name": "Lucy F Hemsley-Faulconbridge, PhD", 
                "role": "Principal Investigator"
            }, 
            "status": "Recruiting"
        }, 
        "location_countries": {
            "country": "United States"
        }, 
        "number_of_arms": "3", 
        "official_title": "Treatment of Obesity in Depressed Individuals: A Randomized Controlled Trial", 
        "other_outcome": {
            "measure": "Changes in mood", 
            "safety_issue": "No", 
            "time_frame": "Baseline to 20 weeks of treatment, follow up at week 46"
        }, 
        "overall_contact": {
            "email": "lucyhf@mail.med.upenn.edu", 
            "last_name": "Lucy F Hemsley-Faulconbridge, PhD", 
            "phone": "215-746-7191"
        }, 
        "overall_official": {
            "affiliation": "University of Pennsylvania Center for Weight and Eating Disorders", 
            "last_name": "Lucy F Hemsley-Faulconbridge, PhD", 
            "role": "Principal Investigator"
        }, 
        "overall_status": "Recruiting", 
        "oversight_info": {
            "authority": "United States: Data and Safety Monitoring Board", 
            "has_dmc": "Yes"
        }, 
        "phase": "N/A", 
        "primary_completion_date": {
            "#text": "March 2015", 
            "@type": "Anticipated"
        }, 
        "primary_outcome": {
            "description": "To determine whether depressed, obese individuals who receive the combined treatment of cognitive-behavior therapy for depression and behavior modification for weight loss are able to lose 5% of their initial weight at the end of 20 weeks of treatment.", 
            "measure": "Weight loss", 
            "safety_issue": "No", 
            "time_frame": "Baseline to 20 weeks of treatment, follow-up at week 46"
        }, 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT01692574"
        }, 
        "responsible_party": {
            "responsible_party_type": "Sponsor"
        }, 
        "secondary_outcome": {
            "measure": "Changes in metabolic cardiovascular disease risk factors and inflammatory markers", 
            "safety_issue": "No", 
            "time_frame": "Baseline to 20 weeks of treatment, follow up at week 46"
        }, 
        "source": "University of Pennsylvania", 
        "sponsors": {
            "collaborator": {
                "agency": "National Heart, Lung, and Blood Institute (NHLBI)", 
                "agency_class": "NIH"
            }, 
            "lead_sponsor": {
                "agency": "University of Pennsylvania", 
                "agency_class": "Other"
            }
        }, 
        "start_date": "August 2012", 
        "study_design": "Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Factorial Assignment, Masking: Open Label, Primary Purpose: Treatment", 
        "study_type": "Interventional", 
        "verification_date": "September 2012"
    }
}